We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIO
2451
DELISTED
City Office REIT
CIO
$148K ﹤0.01%
+10,774
New +$137K
KGC icon
2452
Kinross Gold
KGC
$32.6B
$148K ﹤0.01%
35,000
MITK icon
2453
Mitek Systems
MITK
$838M
$148K ﹤0.01%
15,581
SGYP
2454
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$147K ﹤0.01%
50,707
+100
+0.2% +$341
BCRX icon
2455
BioCryst Pharmaceuticals
BCRX
$2.71B
$146K ﹤0.01%
+27,923
New +$143K
AWRE icon
2456
Aware
AWRE
$26M
$139K ﹤0.01%
29,900
FLWS icon
2457
1-800-Flowers.com
FLWS
$262M
$139K ﹤0.01%
14,140
ENZ
2458
DELISTED
Enzo Biochem, Inc.
ENZ
$138K ﹤0.01%
13,209
AREX
2459
DELISTED
Approach Resources Inc.
AREX
$138K ﹤0.01%
55,021
STRR
2460
DELISTED
Star Equity Holdings
STRR
$137K ﹤0.01%
792
OAKS
2461
DELISTED
Five Oaks Investment Corp.
OAKS
$136K ﹤0.01%
30,565
AGEN
2462
Agenus
AGEN
$311M
$135K ﹤0.01%
1,554
SALM
2463
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$135K ﹤0.01%
20,481
NEWS
2464
DELISTED
NewStar Financial, Inc.
NEWS
$131K ﹤0.01%
11,176
FCEL icon
2465
FuelCell Energy
FCEL
$1.73B
$129K ﹤0.01%
205
GNRT
2466
DELISTED
Gener8 Maritime, Inc.
GNRT
$129K ﹤0.01%
28,510
VRN
2467
DELISTED
Veren
VRN
$128K ﹤0.01%
15,929
+46
+0.3% +$336
CRBP icon
2468
Corbus Pharmaceuticals
CRBP
$189M
$125K ﹤0.01%
+584
New +$114K
ZN
2469
DELISTED
Zion Oil & Gas, Inc.
ZN
$125K ﹤0.01%
36,700
+15,600
+74% +$57.3K
DGII icon
2470
Digi International
DGII
$3.23B
$124K ﹤0.01%
11,741
SNCR
2471
DELISTED
Synchronoss Technologies
SNCR
$124K ﹤0.01%
1,479
VOXX
2472
DELISTED
VOXX International Corporation Class A
VOXX
$123K ﹤0.01%
14,420
PZN
2473
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$123K ﹤0.01%
11,340
RBBN icon
2474
Ribbon Communications
RBBN
$372M
$121K ﹤0.01%
15,832
VHC icon
2475
VirnetX Holding Corp
VHC
$65.8M
$117K ﹤0.01%
1,502

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.